J. VAN DER VELDEN. UIT HET BUITENLAND

by J. Van Der Velden
Published 1947-03-01

Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma

by V. H. J. van der Velden
Published 1998-01-01

Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization.

by Eva Jager, Vincent H J van der Velden, Jeroen G te Marvelde, Roland B Walter, Zvia Agur, Vladimir Vainstein
Published 2011-01-01

Remote management and education in patients with cardiovascular conditions during COVID-19 and beyond

by Dominik Linz, Rachel M.J. van der Velden, Monika Gawalko, Astrid N.L. Hermans, Nikki A.H.A. Pluymaekers, Jeroen M. Hendriks
Published 2020-10-01

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients

by Haike M. J. van der Velden, Michelle M. van Rossum, Willeke A. M. Blokx, Jan B. M. Boezeman, Marie-Jeanne P. Gerritsen
Published 2009-01-01

Consultation rate and chlamydia positivity among ethnic minority clients at STI clinics in the Netherlands.

by S B Ostendorf, C J G Kampman, C J P A Hoebe, J van der Velden, J L A Hautvast, C H M van Jaarsveld
Published 2021-01-01

On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through teleconsultations during COVID-19

by Nikki A.H.A. Pluymaekers, Astrid N.L. Hermans, Rachel M.J. van der Velden, Dennis W. den Uijl, Bianca Vorstermans, Saskia Buskes, Jeroen M. Hendriks, Kevin Vernooy, Harry J.G.M. Crijns, Dominik Linz
Published 2020-06-01

Glutathione S-transferase pi modulates NF-κB activation and pro-inflammatory responses in lung epithelial cells

by Jane T. Jones, Xi Qian, Jos L.J. van der Velden, Shi Biao Chia, David H. McMillan, Stevenson Flemer, Sidra M. Hoffman, Karolyn G. Lahue, Robert W. Schneider, James D. Nolin, Vikas Anathy, Albert van der Vliet, Danyelle M. Townsend, Kenneth D. Tew, Yvonne M.W. Janssen-Heininger
Published 2016-08-01

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

by Stefania Oliva, Davine Hofste op Bruinink, Lucie Rihova, Mattia D’Agostino, Lucia Pantani, Andrea Capra, Bronno van der Holt, Rossella Troia, Maria Teresa Petrucci, Tania Villanova, Pavla Vsianska, Romana Jugooa, Claudia Brandt-Hagens, Milena Gilestro, Massimo Offidani, Rossella Ribolla, Monica Galli, Roman Hajek, Francesca Gay, Michele Cavo, Paola Omedé, Vincent H. J. van der Velden, Mario Boccadoro, Pieter Sonneveld
Published 2021-06-01

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients

by Robéria Mendonça de Pontes, Juan Flores-Montero, Luzalba Sanoja-Flores, Noemi Puig, Roberto J. Pessoa de Magalhães, Alba Corral-Mateos, Anna Beatriz Salgado, Omar García-Sánchez, José Pérez-Morán, Maria-Victoria Mateos, Leire Burgos, Bruno Paiva, Jeroen te Marvelde, Vincent H. J. van der Velden, Carlos Aguilar, Abelardo Bárez, Aranzazú García-Mateo, Jorge Labrador, Pilar Leoz, Carmen Aguilera-Sanz, Brian Durie, Jacques J. M. van Dongen, Angelo Maiolino, Elaine Sobral da Costa, Alberto Orfao
Published 2021-04-01